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Abstract
Polygenic prediction using genome-wide SNPs can provide high prediction accuracy for complex 
traits. Here, we investigate the question of how to account for genetic ancestry when conducting 
polygenic prediction. We show that the accuracy of polygenic prediction in structured populations 
may be partly due to genetic ancestry. However, we hypothesized that explicitly modeling 
ancestry could improve polygenic prediction accuracy. We analyzed three GWAS of hair color, 
tanning ability and basal cell carcinoma (BCC) in European Americans (sample size from 7,440 to 
9,822) and considered two widely used polygenic prediction approaches: polygenic risk scores 
(PRS) and Best Linear Unbiased Prediction (BLUP). We compared polygenic prediction without 
correction for ancestry to polygenic prediction with ancestry as a separate component in the 
model. In 10-fold cross-validation using the PRS approach, the R2 for hair color increased by 66% 
(0.0456 to 0.0755; p<10−16), the R2 for tanning ability increased by 123% (0.0154 to 0.0344; 
p<10−16) and the liability-scale R2 for BCC increased by 68% (0.0138 to 0.0232; p<10−16) when 
explicitly modeling ancestry, which prevents ancestry effects from entering into each SNP effect 
and being over-weighted. Surprisingly, explicitly modeling ancestry produces a similar 
improvement when using the BLUP approach, which fits all SNPs simultaneously in a single 
variance component and causes ancestry to be underweighted. We validate our findings via 
simulations, which show that the differences in prediction accuracy will increase in magnitude as 
sample sizes increase. In summary, our results show that explicitly modeling ancestry can be 
important in both PRS and BLUP prediction.
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Introduction
Genome-wide association studies (GWAS) have identified many single nucleotide 
polymorphisms (SNPs) associated with complex traits [Visscher et al. 2012]. Genetic 
prediction based on genome-wide significant SNPs from GWAS provides some predictive 
ability [Wray et al. 2007; Meigs et al. 2008; Kraft and Hunter 2009; So et al. 2011], but 
polygenic prediction, using genetic variants that do not achieve genome-wide significance, 
can improve prediction accuracy [de los Campos et al. 2010; Chatterjee et al. 2013; 
Dudbridge 2013]. Polygenic prediction has been applied to many complex traits, such as 
schizophrenia and height [Evans et al. 2009; Purcell et al. 2009; Wei et al. 2009; Bush et al. 
2010; Lango Allen et al. 2010; Machiela et al. 2011; Makowsky et al. 2011; Stahl et al. 
2012; Vazquez et al. 2012; Wei et al. 2013; Smoller et al. 2013; Rietveld et al. 2013; Ripke 
et al. 2014; Wood et al. 2014].
Polygenic prediction accuracy may be partly due to genetic ancestry, especially for complex 
traits that are known to be associated with ancestry. For example, differences in height 
between Northern Europeans and Southern Europeans (e.g. due to natural selection) explain 
5% of the variance of height in European Americans from the Framingham Heart Study, 
accounting for most of the polygenic prediction accuracy in 1,997 unrelated individuals 
from this sample [Makowsky et al. 2011; Wray et al. 2013; Turchin et al. 2012]. Other traits 
that are well-known to be associated with ancestry in European-ancestry populations include 
hair color, eye color, skin pigmentation, skin cancer, multiple sclerosis, rheumatoid arthritis, 
type 1 diabetes, Crohn’s disease, Alzheimer’s disease, coagulation factor VII (FVII) plasma 
level, hemoglobin disorders, and educational attainment [Candille et al. 2012; Nan et al. 
2009a; Rosati 2001; Cimmino et al. 1998; Patterson et al. 2009; Kenny et al. 2012; Panza et 
al. 2003; Bernardi et al. 1997; Angastiniotis and Modell 1998; Borjas 1994]. Thus, it is 
possible that polygenic prediction studies of these traits may likewise owe some of their 
accuracy to genetic ancestry [Evans et al. 2009; Wei et al. 2009; Bush et al. 2010; 
Makowsky et al. 2011; Stahl et al. 2012; Vazquez et al. 2012; Wei et al. 2013; Rietveld et al. 
2013]. In genetic association studies, ancestry is a confounder that may cause false positive 
associations with no biological significance [Price et al. 2010]. On the other hand, if the 
ultimate goal is to conduct prediction in the same population, polygenic predictions that are 
partly due to ancestry may be useful. However, it is important to understand how much of 
polygenic prediction accuracy is due to ancestry, as this will affect prediction accuracy in 
other populations.
An open question is how to make use of ancestry information in polygenic prediction. Most 
studies of polygenic prediction ignore ancestry information, but this may not be optimal. We 
propose to correct for ancestry in the polygenic model using principal components, while 
incorporating associations between ancestry and the trait as a separate component in the 
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prediction model. We hypothesize that explicit modeling of ancestry in this fashion can 
improve polygenic prediction accuracy, by preventing ancestry from entering into each SNP 
effect and being overweighted. In this study, we investigated the impact of explicit modeling 
of genetic ancestry on polygenic prediction accuracy by analyzing GWAS samples of 
European Americans for three pigmentation-related traits, including natural hair color (HC), 
childhood and adolescent tanning ability (TA), and basal cell carcinoma (BCC). We 
employed cross-validation schemes to ensure that improvements in prediction accuracy were 
not caused by over-fitting. We determined that explicitly modeling ancestry can 
significantly improve prediction accuracy across different polygenic prediction approaches, 
such as polygenic risk scores and best linear unbiased predictors. We note that although 
polygenic risk scores may not be the optimal prediction method when raw genotypes are 
available, we have chosen to include them as one of the main focuses of our analyses, 
because they are currently the most widely used approach for polygenic risk prediction in 
humans.
Materials and Methods
GWAS data
We performed analyses of 3 genome-wide association studies (GWAS) of hair color (HC), 
tanning ability (TA), and basal cell carcinoma (BCC) nested in the Nurses’ Health Study 
(NHS) and the Health Professionals Follow-up Study (HPFS). The sample collection, 
genotyping and quality control for each GWAS were described previously [Hunter et al. 
2007; Nan et al. 2011; Qi et al. 2010; Rimm et al. 1991; Curhan and Taylor 2008; Taylor et 
al. 2005]. All samples are self-reported European Americans. We included only SNPs 
genotyped with call rate >99% and minor allele frequency >1% and excluded A/T and C/G 
SNPs to avoid strand ambiguity. The missing genotypes were mean-imputed in the 
subsequent analyses. We extracted samples with complete phenotype and self-reported 
ancestry information into 3 GWAS sets. We obtained 7,440 samples with HC, 9,822 
samples with TA, and 2,086 BCC cases and 6,173 controls. We applied LD pruning by 
genomic position with a R2 threshold of 0.2 to obtain 71,557, 71,549 and 71,575 
independent SNPs for HC, TA, and BCC, respectively.
In addition to the genotyped SNPs, we obtained imputed genotypes for variants that showed 
genome-wide significant association with HC, TA and BCC. This included 12 SNPs and one 
two-SNP haplotype associated with each of HC, TA and BCC and 6 additional SNPs 
associated with BCC only (Table S1) [Gerstenblith et al. 2010]. Note that some of these 
genome-wide significant SNPs were identified in the samples analyzed here, especially for 
TA; therefore, higher prediction accuracy based these genome-wide significant SNPs is 
expected [Han et al. 2008; Nan et al. 2009a; Nan et al. 2009b]. The imputation was done 
with using BEAGLE (for phasing) and MaCH using the 1000 Genomes Project Interim 
Phase I release as the reference panel [The 1000 Genomes Project Consortium 2012; Li et 
al. 2010; Browning and Browning 2007].
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Phenotype definitions
The phenotype information was collected from prospective questionnaires. The natural hair 
color at 20 years of age was collected in 4 levels: blonde, light brown, dark brown, and 
black. We excluded samples with red hair color, which is a distinct trait from other hair 
colors and is mainly determined by the MC1R gene [Han et al. 2008]. The childhood and 
adolescent tanning ability with more than 2 hours of sun light exposure was collected in 4 
levels: practically none, light tan, average tan, and deep tan. A previous study showed that 
deeper tan denotes a better response to sun light exposure and is associated with lower risk 
of skin cancer [Nan et al. 2009a]. Both hair color and tanning ability were analyzed as 
quantitative traits. The BCC cases were identified through biennial self-report; the validation 
rate of BCC self-reports was 90% in NHS and HPFS [Han et al. 2006; Hunter et al. 1990].
Self-reported ancestry
The participants were assigned to 1 of the 4 self-reported ancestry groups: Scandinavian, 
Southern European, Ashkenazi Jewish, and Other European (which includes samples with 
no self-reported European sub-population ancestry information). We calculated the mean 
and standard deviation for each trait by self-reported ancestry groups. We also tested for 
association between self-reported ancestry and each trait with a Wald test for HC and TA 
and a χ2 test and odds ratios with 95% confidence intervals for BCC.
Inference of genetic ancestry
To infer genetic ancestry, we performed principal component analysis (PCA) with 
EIGENSTRAT software to obtain principal components as measure of genetic ancestry 
[Price et al. 2006; Patterson et al. 2006]. We performed PCA on the 3 GWAS and obtained 
the top 10 PCs specific to each GWAS. These PCs were used in all primary analyses. We 
also performed additional analyses in which we derived the top PCs independently for 
training and validation sets with an external European American reference panel (see 
Discussion). We plotted PC1 and PC2 to show the structure of these GWAS samples with 
color-coding by self-reported ancestry. To further investigate population structure, we 
projected the samples from Eastern European countries in the Population Reference Sample 
(POPRES) to the PC space derived from the TA GWAS samples, which contained most of 
our merged GWAS samples. The collections and methods for the Population Reference 
Sample (POPRES) are described by Nelson et al. (2008). The datasets used for the analyses 
described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/
projects/gap/cgibin/study.cgistudy_id=phs000145.v1.p1 through dbGaP accession number 
phs000145.v1.p1. The PC projection was done by applying the SNP weights, which were 
calculated with principal components and eigenvalues derived from the TA GWAS samples, 
to the POPRES samples [Chen et al. 2013]. To compare the structure of POPRES samples 
and our GWAS samples, we plotted the projected PC1 and PC2 of POPRES samples with 
the PC1 and PC2 of the TA GWAS samples.
Prediction using genetic and self-reported ancestry
We demonstrated the prediction ability of ancestry by building prediction models with 1) 
self-reported ancestry, 2) PC1 and PC2, 3) the top 5 PCs, and 4) the top 5 PCs plus self-
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reported ancestry in all samples. To control for over-fitting, we also employed 10-fold cross-
validation: we built prediction models by estimating model coefficients with the training set 
which includes 90% of the total sample size and applied the estimated model coefficients to 
the validation set, which includes 10% of the total sample size excluded from the training 
set, and calculated predicted phenotypes for the validation samples. A predicted phenotype 
was calculated for each validation sample as  where k indexes the predictors, 
including PCs and/or self-reported ancestry, βk is the regression coefficient estimated in the 
training set and xk is the covariate value for the validation set. We repeated this process 10 
times and pooled the validation samples with predicted phenotypes to calculate out-of-
sample R2 between predicted and true phenotypes. We note that the PCs used in all primary 
analyses were derived with all samples together.
R2 was calculated for each model and a likelihood ratio test (LRT) was used to compare 
models. We used R2 on the observed scale for HC and TA and R2 on the liability scale for 
BCC. The R2 on the observed scale were obtained by fitting linear regression models with 
HC and TA as continuous outcomes and with self-reported ancestry and PCs as predictors. 
To obtain the R2 on liability scale for BCC, we first obtained R2 on the observed scale for 
BCC by treating the BCC case-control status as a continuous outcome where all BCC cases 
take value 1 and controls take value 0 and fitted linear regression models with the 
continuous BCC outcome and the predictors. We then transformed the R2 on the observed 
scale for BCC to the R2 on the liability scale by applying the method based on the liability 
threshold model described in Lee et al. 2012. The transformation of observed scale R2 to 
liability scale R2 assumes a disease liability that follows the standard normal distribution 
and assumes all disease cases have disease liability exceeding a certain threshold value. We 
determined the threshold based on the population prevalence of the disease estimated in 
previous studies [Lear and Smith 1997; Lee et al. 2012]. The transformation is 
 where  and 
. K is the population prevalence of BCC (0.3); t is the threshold 
according to K (0.52); Z is the height of a normal density at the threshold (0.35); m is the 
mean liability for BCC cases (1.16); P is the proportion of BCC cases in the case-control 
sample (0.25). In all analyses, the observed scale and liability scale R2 were obtained using 
the same method. To obtain the LRT p-values, we used linear regression for HC and TA and 
logistic regression for BCC.
Prediction using Genetic Risk Scores (GRS) based on genome-wide significant SNPs
We built prediction models based on genetic risk scores (GRS) using genome-wide 
significant SNPs associated to HC, TA and BCC and compared GRS models to models 
based on both GRS and ancestry. We considered prediction models including 1) GRSunadj, 
2) GRSadj, 3) GRSadj and the top 5 PCs, and 4) GRSadj and the top 5 PCs and self-reported 
ancestry (described in detail below). We employed both 10-fold cross-validation, which 
gives in-sample R2, and 10×9-fold nested cross-validation which gives out-of-sample R2 
that accounts for model over-fitting.
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For 10-fold cross-validation, we estimated effect sizes of the known associated SNPs in the 
training sets by fitting the following models in the 90% training samples:
(1)
or
(2)
where SNPj is the genotype of genome-wide significant SNP j and GWAS is a 6×1 vector of 
6 indicator variables indicating which of the 7 individual GWAS the sample is from. We 
then applied the effect size estimates to the validation samples to construct GRSunadj. We 
calculated GRSunadj for the 10% validation samples by
(3)
where β̂unadj, j is the estimated regression coefficient using the training samples from model 
(1) and (2) and SNPi,j is the genotype of validation sample i at SNP j. We also calculated 
GRSadj by fitting models:
(4)
or
(5)
where SNPj and GWAS are as previously defined and PC is a 5×1 vector of the top 5 PCs. 
The GRSadj was then calculated as
(6)
where β̂adj, j were estimated from model (4) and (5). We then pooled the samples from 10 
mutually exclusive validation sets with GRSunadj and GRSadj constructed with estimates 
from their corresponding training samples and fitted models. In-sample R2 and LRT p-
values were calculated in the validation set for these models, where GRS and other 
predictors (PCs/self-reported ancestry) we treated as univariate predictors.
For the 10×9-fold nested cross-validation, the GWAS samples were split into 2 parts with 
90% of the total samples as the training set and 10% of the total samples as validation set in 
each fold of the nested cross-validation. For the 90% training set, we further split the 
samples into 2 training sets. The first training set had 80% of the total samples and the 
second training set had 10% of the total samples. We used the first training set to estimate 
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effect sizes of the genome-wide significant SNPs and used those effect sizes to construct the 
GRS for the second training set as well as the validation set. We then fit prediction models 
that include GRS (and PCs/self-reported ancestry) in the second training set. The predicted 
phenotype was calculated for each validation sample as  where k index the 
predictors, including GRS and/or PCs/self-reported ancestry, βk is the regression coefficient 
estimated in the second training set and xk is the covariate value for the validation sample. 
For each of the 10 folds of validation samples, we repeated this model building process for 
each of the 9 folds of first and second training sets and averaged the predicted phenotypes of 
validation samples across the 9 folds. With the pooled validation samples from the 10×9-
fold nested cross-validation, we calculated out-of-sample R2 between true phenotypes and 
predicted phenotypes. The out-of-sample R2 were always calculated between a single 
predicted phenotype (Ŷ) and the true phenotype of validation samples and the potential 
inflation of R2 due to increased number of predictors was eliminated. We note that the PCs 
used in all primary analyses were derived with all samples together.
Polygenic prediction using Polygenic Risk Scores (PRS) based on genome-wide SNPs
For the polygenic model with explicit modeling of ancestry, we adjusted for the top 5 PCs 
when constructing the PRS and added the top 5 PCs to the polygenic model as additional 
covariates. We compared prediction models constructed with 1) PRSunadj, 2) PRSadj, 3) 
PRSadj and the top 5 PCs, and 4) PRSadj and the top 5 PCs and self-reported ancestry. We 
first did the analyses with 10-fold cross-validation using R2 and likelihood ratio test as 
figures of merit and then repeated the analyses in 10×9-fold nested cross-validation. Both 
10-fold cross-validation and 10×9-fold nested cross-validation were performed in a similar 
fashion as described above for GRS model comparisons.
We adopted the polygenic risk score method to build polygenic prediction models [Evans et 
al. 2009; Purcell et al. 2009]. We used around 72,000 LD-pruned, independent genome-wide 
SNPs in PRS. To construct PRS without ancestry correction (PRSunadj), we fitted regression 
models (1) and (2) for each of the independent genome-wide SNPs individually using the 
90% training samples. To construct PRS with ancestry correction (PRSadj), we fitted models 
(4) and (5) for each independent genome-wide SNP individually. The β̂unadj, j and β̂adj, j 
were used as weights to construct PRSunadj and PRSadj, respectively. Models (3) and (6) 
were used to construct PRS, except that we included all independent genome-wide SNPs in 
the PRS. We also constructed PRSunadj and PRSadj using different numbers of genome-wide 
SNPs determined by the association p-value (calculated for each training set) for the SNP 
and the target phenotype: 5×10−8, 1×10−7, 1×10−6, 1×10−5, 1×10−4, 0.001, 0.01, 0.05, 0.1, 
0.5, and 1.0. For BCC, we did not construct PRS with p-value threshold smaller than 1×10−5 
because no SNP showed association p-value smaller than 1×10−5 for BCC in our data.
We further extended the polygenic models above to include 1) both GRSunadj and 
PRSunadj,-gs, 2) both GRSadj and PRSadj,-gs, 3) both GRSadj and PRSadj,-gs plus the top 5 
PCs, and 4) both GRSunadj and PRSunadj,-gs plus the top 5 PCs. Here, PRSunadj,-gs and 
PRSadj,-gs are PRS that excluded SNPs with genome-wide significant association for the 
target trait in previous GWAS (which are included in GRS), and SNPs in LD with those 
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genome-wide significant SNPs (pairwise R2 > 0.2). The GRS and PRS were combined in the 
prediction model by either summing the GRS and PRS to make one score or including GRS 
and PRS as two separate components of the model.
We used in-sample R2 and LRT to compare these models in the validation set in the 10-fold 
cross-validation, where all predictors were treated as univariate predictors in the model. We 
calculated out-of-sample R2 in the 10×9-fold nested cross-validation, where the predicted 
phenotypes for each validation sample were calculated as  where k index the 
predictors, including PRS and/or PCs/self-reported ancestry, βk is the regression coefficient 
estimated in the second training set and xk is the covariate value for the validation sample. 
We note that the PCs used in all primary analyses were derived with all samples together.
Polygenic prediction using Best Linear Unbiased Predictors (BLUP) based on genome-
wide SNPs
In addition to PRS, we performed polygenic prediction based on BLUP by fitting linear 
mixed models to estimate genome-wide SNP effect sizes simultaneously [Yang et al. 2010]. 
We compared prediction models based on 1) BLUPunadj, 2) BLUPadj, 3) BLUPadj plus the 
top 5 PCs, 4) BLUPunadj,-gs, 4) BLUPadj,-gs, and 5) BLUPadj,-gs plus the top 5 PCs, where –
gs denotes excluding genome-wide significant SNPs from the random effects of linear 
mixed model and entered the model as fixed effects. We note that the PCs used in all 
primary analyses were derived with all samples together. We adopted 10-fold cross-
validation to fit linear mixed models in the 90% training samples and output the random 
effects and fixed effects estimates with GCTA. The linear mixed model we used to obtain 
effect size estimates takes the general form:
(7)
where β is a vector of fixed effects, g is the total genetic effects of the training samples with 
, A is the genetic relationship matrix derived from SNP genotypes, ε is the 
residual with  [Yang et al. 2010]. In our case, the fixed effects included 
individual GWAS study indicator, PCs, and/or genome-wide significant SNPs. The effect 
sizes of SNPs used to calculate PRS were calculated as  where V−1 is the 
inverse of the phenotypic covariance matrix of the training samples and m is the number of 
SNPs used to calculated the genetic relationship matrix. We then apply the effect estimates 
to the 10% validation samples to construct PRS, GRS, and PCs. The calculation of PRS in 
the validation samples is the same as models (3) and (6). We used in-sample R2 and LRT to 
compare these models in the 10-fold cross-validation with the pooled validation samples, 
where all predictors were treated as univariate predictors in the model.
Simulations comparing polygenic prediction using polygenic risk scores
It is widely known that polygenic prediction accuracy is predominantly determined by the 
training sample size. In our analysis using real GWAS samples, the training sample size is 
fixed. To examine the performance of different PRS approaches under different training 
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sample sizes, we performed the following simulation study. We simulated a quantitative trait 
with 100,000 independent SNPs, where all SNPs were causal and the proportion of 
phenotypic variance explained by these SNPs was 0.5. We simulated sets of 1,000, 5,000, 
10,000, 50,000, 100,000, 500,000, 1,000,000 training samples and 10,000 validation 
samples. Training samples and validation samples were each drawn from two 
subpopulations POP1 and POP2, with minor allele frequency equal to 0.50 in POP1 and 
drawn from a normal distribution with mean 0.50 and standard deviation 0.05 in POP2, so 
that the fixation index FST(POP1, POP2)=0.005. The signs of marker effect sizes were 
flipped so that with probability 0.51, the allele with higher frequency in POP2 had positive 
effect, with the result that POP2 had systematically higher trait mean and subpopulation 
ancestry had an R2 of 0.044 with the trait. We compared three approaches: PRSunadj, PRSadj, 
and PRSadj + ancestry, which is equivalent to PRSadj + top PC except that ancestry is 
assumed to be inferred with perfect accuracy. (We did not consider additional PCs because 
the data was simulated to contain only one dimension of population structure.) Results were 
averaged across 100 simulations. We compared the simulation results to the results from our 
PRS analysis using real GWAS samples.
Results
Inference of genetic ancestry
We performed analyses in three genome-wide association studies (GWAS) of hair color 
(HC), tanning ability (TA), and basal cell carcinoma (BCC) with samples from the Nurses’ 
Health Study (NHS) and the Health Professionals Follow-up Study (HPFS). We investigated 
the population structure in our GWAS samples using principal component analysis (PCA) 
[Price et al. 2006; Patterson et al. 2006], and compared the top principal components (PCs) 
to self-reported European ancestry. We first plotted PC1 and PC2 to investigate the 
population structure in the three GWAS (Figure 1). The PCA plot was color-coded with self-
reported European ancestry, which has four categories: Scandinavian, Southern European, 
Ashkenazi Jewish, and Other European. We found that samples of self-reported Southern 
European ancestry had relatively lower PC1 values than samples of self-reported 
Scandinavian ancestry, while self-reported Ashkenazi Jewish samples had the lowest PC1 
on average. In addition, the average PC1 and PC2 of Other European samples are close to 
the average PC1 and PC2 of Scandinavian samples, suggesting that Other European samples 
are predominantly of Northern European ancestry. The structure we identified in our GWAS 
sample is different from the canonical PC1 and PC2 in European American samples shown 
in Price et al. (2008) perhaps because the current data set has more samples of Eastern 
European ancestry than the samples analyzed in that paper. By projecting POPRES samples 
onto PC1 and PC2, we determined that samples with high PC2 value represent Eastern 
European ancestry (Figure S1) [Nelson et al. 2008]. This result suggests that lower PCs may 
capture additional structure. In the prediction analyses below, we include either PC1 and 
PC2 or the top 5 PCs; including more than 5 PCs (up to 10 PCs) did not change any of the 
results.
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Prediction using genetic and self-reported ancestry
Pigmentation-related traits are associated with ancestry, due to positive selection on lighter 
pigmentation in populations in regions of higher latitude [Sulem et al. 2007]. Indeed, our 
data showed that HC, TA and BCC are strongly associated with genome-wide ancestry and 
self-reported ancestry (Table 1). Compared with self-reported Scandinavian samples, 
Southern European samples on average have darker hair color (2.60 in Southern European 
vs. 2.08 in Scandinavian), increased tanning ability (2.67 in Southern European vs. 2.36 in 
Scandinavian), which corresponds to better protection against ultraviolet radiation, and 
lower risk of BCC (odds ratio [OR] for Scandinavian vs. Southern European (ref) = 1.075, 
95% confidence interval [CI]: 1.036, 1.116). Ashkenazi Jewish samples on average had the 
darkest hair color (2.76), which is consistent with their lower PC1 value vs. South 
Europeans, but also had the lowest tanning ability (2.30) and highest risk of BCC among 4 
self-reported ancestry groups (OR = 1.123, 95% CI: 1.074, 1.174), which are not consistent 
with their lower PC1 value vs. South Europeans. The Scandinavian samples had similar but 
slightly more extreme phenotypes than the Other European samples, consistent with the 
similar but slightly higher average PC1 for Scandinavian vs. Other European samples.
Motivated by these observations, we fitted prediction models based on ancestry. We first 
examined models based on self-reported ancestry only, where the in-sample R2 was 0.0397 
for HC, 0.0081 for TA, and 0.0072 for BCC (Table 2). We then examined prediction models 
based on PCs only. The model based on top 5 PCs achieved R2 of 0.0724 for HC, 0.0350 for 
TA, and 0.0202 for BCC in the in-sample analysis (Table 2). We also showed that adding 
PC3 to PC5 in addition to PC1 and PC2 improved model prediction accuracy significantly 
for all 3 phenotypes (p < 10−16 for HC and TA; 1.93×10−15 for BCC). This suggests that 
including the subtle structure captured by later PCs provided additional value in predicting 
these phenotypes. However, including more than 5 PCs did not change any of the results. 
The R2 obtained by using self-reported ancestry are lower than the R2 obtained by using the 
top 5 PCs. Interestingly, we found including self-reported ancestry in the models in addition 
to the top 5 PCs further improved prediction accuracy (Table 2). The improvement was 
significant for HC (p = 1.32×10−9) and TA (p = 5.70×10−3) but not for BCC (p = 0.18) in 
the in-sample analysis. In addition, we showed that the added information in self-reported 
ancestry for HC (where this effect is strongest) is primarily due to self-reported 
Scandinavian ancestry, which is not completely captured by the Northwest-Southeast 
European cline of PC1 (Table S2). We also performed out-of-sample analyses using 10-fold 
cross-validation and obtained similar results (Table S3). Overall, we showed that both PCs 
and self-reported ancestry explained part of the phenotypic variation and can be used to 
build prediction models for these pigmentation-related traits. Furthermore, while models 
based on PCs have higher prediction accuracy than models based on self-reported ancestry, 
self-reported ancestry can still improve prediction accuracy over PCs.
Prediction using Genetic Risk Scores (GRS) based on genome-wide significant SNPs
To investigate the potential improvement of genetic risk prediction models by incorporating 
ancestry information, we compared genetic risk prediction models based on genetic risk 
scores (GRS) [Meigs et al. 2008]. We used imputed genotypes of SNPs shown to be 
genome-wide significant in previous GWAS to create GRS for each of the 3 phenotypes 
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(Table S1). The models we compared included GRS without ancestry correction (GRSunadj), 
GRS with ancestry correction (adjusted for the top 5 PCs) (GRSadj), and GRS with explicit 
modeling of ancestry (GRSadj+PCs). In 10-fold cross-validation, GRSunadj attained an R2 of 
0.2236 for HC (p < 10−16), 0.1311 for TA (p < 10−16), and 0.0266 (p < 10−16) for BCC 
(Table 3). The R2 of GRSadj were lower than the R2 of GRSunadj for HC and BCC, but 
slightly higher for TA (R2 = 0.1324). In 10×9-fold nested cross-validation, the R2 of GRSadj 
were consistently lower than R2 of GRSunadj for all 3 phenotypes (Table S3). The R2 of 
GRSunadj and GRSadj were much higher than the models based on ancestry. However, we 
showed that the prediction accuracy was improved (relative to either GRSunadj or GRSadj) 
by including PCs in the GRSadj model (Table 3). We repeated the GRSunadj, GRSadj and 
GRSadj+PCs model comparison by fitting all known genome-wide significant SNPs in one 
model simultaneously to obtain effect size estimates for constructing GRS (Table S4). The 
results showed similar patterns to the results from fitting genome-wide significant SNPs 
individually (Table 3). The improvement also remains for the out-of-sample R2 from 10×9-
fold nested cross-validation (Table S3). We also calculated the R2 between the top 5 PCs 
and the predicted phenotypes based on GRSunadj and GRSadj (Table S5). We found that the 
R2 between PCs and GRSadj were only slightly lower than the R2 between PCs and 
GRSunadj, which suggests that the genome-wide significant SNPs used to calculate GRS 
have systematically different allele frequencies across European subpopulations, e.g. due to 
natural selection [Turchin et al. 2012]. In addition to PCs, we also showed that including 
self-reported ancestry further improved prediction accuracy on top of GRSadj + PCs for HC 
(R2 from 0.2378 to 0.2423; p = 1.24×10−9) and TA (R2 from 0.1384 to 0.1397; p = 
2.73×10−3), but not BCC (R2 from 0.0372 to 0.0385; p = 0.108) (Table S6).
Polygenic prediction using Polygenic Risk Scores (PRS) based on genome-wide SNPs
We investigated the impact of explicitly modeling ancestry on polygenic prediction by 
comparing 3 polygenic models: 1) the polygenic risk score (PRS) without ancestry 
correction (PRSunadj), 2) a polygenic risk score with correction for ancestry (PRSadj), and 3) 
a polygenic model with explicit modeling of ancestry, where we corrected for ancestry but 
added a separate ancestry component (PRSadj+PCs) [Purcell et al. 2009; Evans et al. 2009]. 
We compared PRS models with PRS that included all available SNPs across the genome 
after LD pruning. Results are displayed in Table 4. Comparing PRSadj+PCs to PRSunadj, the 
R2 improved 67% (from 0.0473 to 0.0789) for hair color, 114% (from 0.0162 to 0.0347) for 
tanning ability and 62% (from 0.0145 to 0.0235) for BCC. The model improvements were 
significant with p-value < 10−16. We found that PRSadj attained a lower R2 than the other 
models (0.0055 for HC; 0.0003 for TA; 0.0029 for BCC). Notably, the improvement in R2 
of PRSadj+PCs over PRSadj was much larger than the R2 of PRSunadj in each case, 
suggesting that PRSunadj suffered from a mis-specified weighting of ancestry effects, which 
enter into each SNP effect in the unadjusted model. The low R2 of PRSadj is consistent with 
the relatively small sample size in our analyses [Chatterjee et al. 2013; Dudbridge 2013], 
and indicates that the prediction accuracy of PRSunadj was largely due to ancestry. Indeed, 
we observed R2 as large as 0.9250 between PC1 and PRSunadj (Table S5). This is consistent 
with our simulations, in which the prediction R2 for PRSunadj was consistently biased toward 
the same number, 0.044, which is the R2 between ancestry and the target trait. However, the 
prediction R2 of PRSadj increased from 0.003 to 0.439 as the training sample size increased 
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from 1,000 to 1,000,000, and PRSadj+ancestry consistently outperformed both PRSunadj and 
PRSadj (Table 5). Results for PRSadj were close to the values predicted by theory in the 
absence of ancestry effects (see Equation (1) of Wray et al. 2013 Nat Rev Genet) [Wray et 
al. 2013]. These simulations show that explicit modeling of genetic ancestry can improve 
polygenic prediction accuracy, and that the magnitude of this improvement can become 
extremely large as sample sizes grow.
We also compared the 3 types of polygenic models with GRSunadj or GRSadj included as a 
component separate from PRSunadj or PRSadj in the model (PRSunadj + GRSunadj, PRSadj + 
GRSadj, and PRSadj + GRSadj + PCs). We excluded genome-wide significant SNPs (and 
SNPs in LD with known associated SNPs) from PRSunadj and PRSadj, since GRS based on 
genome-wide significant SNPs were included in the model as a separate component. 
Comparing the models with both PRS + GRS to the models with PRS only, the R2 in general 
improved and the improvements were consistent with the R2 from the GRS models (Table 
4). The improvement in R2 due to explicit modeling of ancestry remained but with a smaller 
magnitude, similar to the analysis using GRS only (Table 3); similar relative results were 
obtained when using GRSadj in each model. For the PRS + GRS analyses, we also 
constructed GRS by fitting all known genome-wide significant SNPs in one model 
simultaneously to obtain effect size estimates (Table S7). The results showed similar 
patterns to the results from fitting genome-wide significant SNPs individually (Table 4). We 
also performed out-of-sample analyses using 10×9-fold nested cross-validation and obtained 
similar results (Table S3).
In addition to the 3 polygenic models described above, we evaluated the models of 
PRSunadj+PCs and PRSunadj+GRSunadj+PCs and found that these models attained lower R2 
than PRSadj + PCs and PRSadj+GRSadj+PCs (Table 4). This result may be caused by the fact 
that PRSunadj and PCs are correlated due to ancestry information in both, which is not 
optimally modeled. Finally, we considered models including self-reported ancestry in 
addition to PCs as ancestry measures. The polygenic models with explicit modeling of 
ancestry were further improved by self-reported ancestry for HC and TA, but not BCC 
(Table S6), consistent with predictions using ancestry only (Table 2).
In addition to using all independent SNPs across the genome to construct PRS, we applied a 
p-value threshold based on association tests between individual SNPs and corresponding 
phenotypes to select SNPs entering PRS. We used p-value thresholds from 5×10−8 to 1 and 
constructed PRS corresponding to each p-value threshold [Evans et al. 2009; Purcell et al. 
2009]. We fitted the 3 types of polygenic models with PRS only and the 3 types of 
polygenic models with both PRS and GRS, using PRS subject to different p-value thresholds 
(Figure 2). The prediction accuracy for the polygenic models varied with p-value thresholds 
and showed different patterns for the 3 traits. The R2 of PRSadj+PCs model for HC and TA 
increased with more stringent p-value threshold, while R2 of PRSadj+PCs model for BCC 
remained stable. Overall, polygenic models with explicit modeling of ancestry had higher R2 
than models without ancestry correction across all p-value thresholds applied to PRS. In 
addition, the difference between R2 from the model with explicit modeling of ancestry and 
the model without ancestry correction remained constant across p-value thresholds. For the 
PRS only models, the R2 changed with the p-value threshold for PRS but the magnitude of 
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change was relatively small. For the models with both PRS and GRS components, the R2 
were still improved with a smaller magnitude by explicitly modeling ancestry, compared 
with PRS only models. We also repeated the analyses in 10×9-fold nested cross-validation 
and the results were similar to 10-fold simple cross-validation (Figure S2). Overall, we 
showed that explicit modeling of genetic ancestry improves polygenic prediction accuracy, 
and that this pattern persists when including known associated SNPs via a GRS, and when 
using p-value thresholds.
Polygenic prediction using Best Linear Unbiased Predictors (BLUP) based on genome-
wide SNPs
As a comparison to PRS, which use SNP effect sizes obtained by fitting models for each 
SNP individually, we compared the 3 types of polygenic models based on best linear 
unbiased predictors (BLUP), which use SNP effect sizes obtained by fitting all SNPs using a 
linear mixed model [Henderson 1975; Haile-Mariam et al. 2013; de los Campos et al. 2013; 
Habier et al. 2013; Bolormaa et al. 2013]. We created 3 polygenic models: BLUP without 
ancestry correction (BLUPunadj); BLUP with ancestry correction (BLUPadj); and BLUP with 
explicit modeling of ancestry (BLUPadj+PCs); in BLUPadj and BLUPadj+PCs, ancestry was 
modeled using fixed effects (see Methods). In general, the R2 of BLUP exhibited similar 
patterns as the R2 of PRS (Table 6). In particular, BLUPadj+PCs substantially outperformed 
BLUPunadj. As with PRS, the improvement in R2 of BLUPadj+PCs over BLUPadj was much 
larger than the R2 of BLUPunadj in each case, suggesting that BLUPunadj suffered from a 
mis-specified weighting of ancestry effects; although BLUP fits all SNPs simultaneously, it 
does not allow for different weights for different ancestry effects (e.g. PCs). BLUPadj had 
low R2 due to small sample size, indicating that the prediction accuracy of BLUPunadj was 
largely due to ancestry (Table S5). In models with BLUP and GRS as 2 separate 
components (where genome-wide significant SNPs were included in the GRS but not in 
BLUP), BLUPadj+GRSadj+PCs had significantly higher R2 than BLUPunadj+GRSunadj 
(Table 6). Adding self-reported ancestry in the BLUPadj+GRSadj+PCs and the 
BLUPadj+PCs models improves the prediction accuracy significantly for HC and TA, but 
not BCC (Table S6).
Discussion
Polygenic prediction using genome-wide SNPs has been widely applied to many complex 
traits. The most widely used polygenic prediction method is to construct a polygenic risk 
score (PRS), which is the sum of allele counts weighted by effect sizes estimated 
individually for each SNP, optionally restricting to SNPs with association p-value below a 
certain threshold [Chatterjee et al. 2013; Dudbridge 2013]. (It has previously been noted 
(Chatterjee et al. 2013) that other model selection and shrinkage methods, such as least 
absolute shrinkage and selection operator (LASSO)-type threshold methods that analyze all 
SNPs simultaneously, may modestly outperform the standard polygenic prediction 
approach). In previous studies using PRS, some of them adjusted for ancestry (PRSadj) 
[Purcell et al. 2009; Stahl et al. 2012; Smoller et al. 2013; Rietveld et al. 2013, PGC 2014 
Nature], and some of them did not (PRSunadj) [Evans et al. 2009; Bush et al. 2010; Lango 
Allen et al. 2010; Machiela et al. 2011; Wood et al. 2014 Nat Genet]. However, a separate 
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point is that modeling genetic ancestry as a separate component (PRSadj+PCs) can improve 
polygenic prediction accuracy relative to either PRSunadj or PRSadj, as we showed for HC, 
TA and BCC; the same result is expected to hold for other traits associated to ancestry in 
subtly structured populations; this could explain why recent GWAS of height, which have 
reported that their association results may be impacted by very subtle population 
stratification [Lango Allen et al. 2010; Wood et al. 2014 Nat Genet], have attained 
prediction R2 using PRS that are lower than predicted by theory [Daetwyler et al. 2008 
PLoS ONE]. In addition, the result still holds when including known associated SNPs via a 
genetic risk score (GRS), and when using p-value thresholds. In the European American 
data we analyzed, using 5 PCs to model ancestry improved our results relative to using 2 
PCs. Surprisingly, including self-reported ancestry in addition to 5 PCs improved results 
further, as self-reported ancestry contains information about Scandinavian ancestry that is 
not well-captured by the PCs. Thus, PCs are not guaranteed to capture all ancestry 
information in subtly structured populations.
When applying methods that do not model genetic ancestry as a separate component (e.g. 
PRSunadj or PRSadj), it is still of interest to understand how much of polygenic prediction 
accuracy is due to ancestry, as this will affect prediction accuracy in other populations. For 
example, Rietveld et al. reported a polygenic prediction R2 of 0.02 (p < 10−16) in an analysis 
of unrelated samples but a polygenic prediction R2 of only 0.003 (p = 0.001) in a within-
family analysis immune to ancestry effects (see Table S25 of Rietveld et al.) [Rietveld et al. 
2013]. Unmodeled population structure provides one plausible explanation for this 
discrepancy. We note that although Rietveld et al. adjusted for 4 PCs in their analyses 
(PRSadj), there is no guarantee that PCs capture all ancestry information in subtly structure 
populations. In addition, it is possible that PRSadj+PCs might attain a higher prediction R2 
than PRSadj in unrelated samples in the Rietveld et al. data, as we showed for HC, TA and 
BCC.
A previous study analyzed GWAS data from the Framingham Heart Study to compare 
prediction models for skin cancer risk using either pedigree information, or PCs, or 
polygenic prediction using Bayesian Lasso [Vazquez et al. 2012]. This study reported that 
polygenic prediction attained the highest prediction accuracy, PCs attained the next highest 
prediction accuracy, and pedigree information attained the lowest prediction accuracy. 
However this study did not explicitly model ancestry in the polygenic prediction model. 
Based on our results, it is possible that polygenic prediction with explicit modeling of 
ancestry might attain higher accuracy than the polygenic prediction approach employed by 
ref. [Vazquez et al. 2012]. It is also possible that combining pedigree information with 
polygenic predictions might improve prediction accuracy, although we have not explored 
that approach here [Haile-Mariam et al. 2013].
Alternatives to the widely used PRS approach for polygenic prediction include Best Linear 
Unbiased Prediction (BLUP) and its Bayesian extensions, which fit all markers 
simultaneously [de los Campos et al. 2013; Habier et al. 2013; Zhou et al. 2013; Bolormaa et 
al. 2013]. The potential benefits of explicitly modeling ancestry in this context may depend 
on the prior distribution of effect sizes that is assumed. Under an infinitesimal (Gaussian) 
prior, fitting all marker effects simultaneously may implicitly capture the effects of ancestry. 
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However, our results showed that BLUP still showed an improvement in prediction accuracy 
when explicitly modeling ancestry. Although previous work has argued against including 
PCs as separate fixed effects in a mixed model when estimating components of heritability 
[Janss et al. 2012], and has shown that including PCs as separate fixed effects is generally 
not necessary when using standard mixed model methods for association [Yang et al. 2014], 
those studies did not consider prediction accuracy. Our recommendations for prediction are 
different from those recommendations for heritability estimation and association.
A limitation of our study is that the increased accuracy of PRSadj+PCs (relative to PRSadj) is 
contingent on validation samples having the same population structure as the training 
samples, as was the case in our cross-validation experiments. If validation samples do not 
have the same population structure then prediction accuracy will be lower, although 
PRSadj+PCs is still an appropriate strategy. (For example, if validation samples are from a 
homogeneous population, then PRSadj+PCs will produce predictions virtually identical to 
PRSadj.) Another potential limitation of our study is that it may not be feasible to compute 
PCs by running PCA on raw genotypes from the union of training and validation samples, as 
was done here; for example, this will not be feasible if only summary statistics are available 
for training samples. However, in this case, the top PCs for validation samples can be 
computed using weights derived from external reference panels (as projected PCs), as we 
have described previously [Chen et al. 2013]. We repeated the main analyses with top 
projected PCs derived for both training and validation samples using an external European 
American reference panel and obtained similar results to the results using PCs derived from 
raw genotypes of training and validation samples (Tables S8–S12). (We note that our main 
analyses use only training sample genotypes and phenotypes and validation sample 
genotypes to predict validation sample phenotypes, which is appropriate.)
We conclude by emphasizing the dependence of polygenic prediction accuracy on sample 
size. Both PRSadj (with or without P-value thresholding to impose model selection) and 
BLUPadj attained low R2 in our analyses at modest sample sizes (<10,000), consistent with 
theoretical derivations [Daetwyler et al. 2008; Wray et al. 2013] and simulations suggesting 
that very large training sample sizes (100,000 or more) are needed to achieve high prediction 
accuracy [Chatterjee et al. 2013; Dudbridge 2013]. This limitation is in no way specific to 
the PRS approach. At larger sample sizes, it is likely that polygenic prediction will have 
significant clinical ramifications [Chatterjee et al. 2013; Dudbridge 2013]; indeed, 
prediction R2 has improved in recent very large studies [Ripke et al. 2014]. Notably, our 
simulations specifically show that the impact of explicit modeling of genetic ancestry will 
become extremely large as sample sizes grow.
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Acknowledgments
We are grateful to Mingfeng Zhang, Constance Chen, Naomi Wray and Peter Visscher for helpful discussions and 
to Arti Tandon for assistance with POPRES data. This work was supported by National Institutes of Health grants 
R01 HG006399 (C.Y.C. and A.L.P.) and R01 GM105857.
Chen et al. Page 15
Genet Epidemiol. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
References
Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci. 1998; 
850:251–69. [PubMed: 9668547] 
Bernardi F, Arcieri P, Bertina RM, Chiarotti F, Corral J, Pinotti M, Prydz H, Samama M, Sandset PM, 
Strom R, et al. Contribution of Factor VII Genotype to Activated FVII Levels: Differences in 
Genotype Frequencies Between Northern and Southern European Populations. Arterioscler Thromb 
Vasc Biol. 1997; 17:2548–553. [PubMed: 9409226] 
Bolormaa S, Pryce JE, Kemper K, Savin K, Hayes BJ, Barendse W, Zhang Y, Reich CM, Mason BA, 
Bunch RJ, et al. Accuracy of prediction of genomic breeding values for residual feed intake, carcass 
and meat quality traits in Bos taurus, Bos indicus and composite beef cattle. J Anim Sci. 2013; 
91:3088–104. [PubMed: 23658330] 
Borjas GJ. The Economics of Immigration. J Econ Lit. 1994; 32:1667–717.
Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for 
whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet. 2007; 
81:1084–97. [PubMed: 17924348] 
Bush WS, Sawcer SJ, de Jager PL, Oksenberg JR, McCauley JL, Pericak-Vance Ma, Haines JL. 
Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come. Am J Hum 
Genet. 2010; 86:621–5. [PubMed: 20362272] 
Candille SI, Absher DM, Beleza S, Bauchet M, McEvoy B, Garrison Na, Li JZ, Myers RM, Barsh GS, 
Tang H, et al. Genome-wide association studies of quantitatively measured skin, hair, and eye 
pigmentation in four European populations. PloS One. 2012; 7(10):e48294. [PubMed: 23118974] 
Chatterjee N, Wheeler B, Sampson J, Hartge P, Chanock SJ, Park J-H. Projecting the performance of 
risk prediction based on polygenic analyses of genome-wide association studies. Nat Genet. 2013; 
45(4):400–5. 405e1–3. [PubMed: 23455638] 
Chen C-Y, Pollack S, Hunter DJ, Hirschhorn JN, Kraft P, Price AL. Improved ancestry inference using 
weights from external reference panels. Bioinformatics. 2013; 29:1399–406. [PubMed: 23539302] 
Cimmino, Ma; Parisi, M.; Moggiana, G.; Mela, GS.; Accardo, S. Prevalence of rheumatoid arthritis in 
Italy: the Chiavari Study. Ann Rheum Dis. 1998; 57:315–8. [PubMed: 9741317] 
Curhan GC, Taylor EN. 24-H Uric Acid Excretion and the Risk of Kidney Stones. Kidney Int. 2008; 
73:489–96. [PubMed: 18059457] 
Daetwyler HD, Villanueva B, Woolliams Ja. Accuracy of predicting the genetic risk of disease using a 
genome-wide approach. PloS One. 2008; 3:e3395. [PubMed: 18852893] 
Dudbridge F. Power and Predictive Accuracy of Polygenic Risk Scores. PLoS Genet. 2013; 
9(3):e1003348. [PubMed: 23555274] 
Evans DM, Visscher PM, Wray NR. Harnessing the information contained within genome-wide 
association studies to improve individual prediction of complex disease risk. Hum Mol Genet. 
2009; 18:3525–31. [PubMed: 19553258] 
Gerstenblith MR, Shi J, Landi MT. Genome-wide association studies of pigmentation and skin cancer: 
a review and meta-analysis. Pigment Cell Melanoma Res. 2010; 23:587–606. [PubMed: 
20546537] 
Habier D, Fernando RL, Garrick DJ. Genomic-BLUP Decoded: A Look into the Black Box of 
Genomic Prediction. Genetics. 2013; 194:597–607. [PubMed: 23640517] 
Haile-Mariam M, Nieuwhof GJ, Beard KT, Konstatinov KV, Hayes BJ. Comparison of heritabilities of 
dairy traits in Australian Holstein-Friesian cattle from genomic and pedigree data and implications 
for genomic evaluations. J Anim Breed Genet. 2013; 130:20–31. [PubMed: 23317062] 
Han J, Kraft P, Colditz GA, Wong J, Hunter DJ. Melanocortin 1 receptor variants and skin cancer risk. 
Int J Cancer. 2006; 119:1976–84. [PubMed: 16721784] 
Han J, Kraft P, Nan H, Guo Q, Chen C, Qureshi A, Hankinson SE, Hu FB, Duffy DL, Zhao ZZ, et al. 
A genome-wide association study identifies novel alleles associated with hair color and skin 
pigmentation. PLoS Genet. 2008; 4:e1000074. [PubMed: 18483556] 
Henderson CR. Best linear unbiased estimation and prediction under a selection model. Biometrics. 
1975; 31:423–47. [PubMed: 1174616] 
Chen et al. Page 16
Genet Epidemiol. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Hunter DJ, Colditz GA, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Risk factors for basal cell 
carcinoma in a prospective cohort of women. Ann Epidemiol. 1990; 1:13–23. [PubMed: 1669486] 
Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, 
Hutchinson A, et al. A genome-wide association study identifies alleles in FGFR2 associated with 
risk of sporadic postmenopausal breast cancer. Nat Genet. 2007; 39:870–4. [PubMed: 17529973] 
Janss L, de Los Campos G, Sheehan N, Sorensen D. Inferences from genomic models in stratified 
populations. Genetics. 2012; 192:693–704. [PubMed: 22813891] 
Kenny EE, Pe’er I, Karban A, Ozelius L, Mitchell AA, Ng SM, Erazo M, Ostrer H, Abraham C, Abreu 
MT, et al. A genome-wide scan of Ashkenazi Jewish Crohn’s disease suggests novel susceptibility 
loci. PLoS Genet. 2012; 8:e1002559. [PubMed: 22412388] 
Kraft P, Hunter DJ. Genetic risk prediction--are we there yet? N Engl J Med. 2009; 360:1701–3. 
[PubMed: 19369656] 
Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, 
Vedantam S, Raychaudhuri S. Hundreds of variants clustered in genomic loci and biological 
pathways affect human height. Nature. 2010; 467:832–8. [PubMed: 20881960] 
Lear JT, Smith AG. Basal cell carcinoma. Postgrad Med J. 1997; 73:538–42. [PubMed: 9373591] 
Lee SH, Goddard ME, Wray NR, Visscher PM. A better coefficient of determination for genetic 
profile analysis. Genet Epidemiol. 2012; 36:214–24. [PubMed: 22714935] 
Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate 
haplotypes and unobserved genotypes. Genet Epidemiol. 2010; 34:816–34. [PubMed: 21058334] 
De los Campos G, Gianola D, Allison DB. Predicting genetic predisposition in humans: the promise of 
whole-genome markers. Nat Rev Genet. 2010; 11:880–6. [PubMed: 21045869] 
De los Campos G, Vazquez AI, Fernando R, Klimentidis YC, Sorensen D. Prediction of Complex 
Human Traits Using the Genomic Best Linear Unbiased Predictor. PLoS Genet. 2013; 
9:e1003608. [PubMed: 23874214] 
Machiela MJ, Chen C-Y, Chen C, Chanock SJ, Hunter DJ, Kraft P. Evaluation of polygenic risk scores 
for predicting breast and prostate cancer risk. Genet Epidemiol. 2011; 35:506–14. [PubMed: 
21618606] 
Makowsky R, Pajewski NM, Klimentidis YC, Vazquez AI, Duarte CW, Allison DB, de los Campos G. 
Beyond missing heritability: prediction of complex traits. PLoS Genet. 2011; 7:e1002051. 
[PubMed: 21552331] 
Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, Manning AK, Florez JC, Wilson 
PWF, D’Agostino RB, et al. Genotype score in addition to common risk factors for prediction of 
type 2 diabetes. N Engl J Med. 2008; 359:2208–19. [PubMed: 19020323] 
Nan H, Kraft P, Hunter DJ, Han J. Genetic variants in pigmentation genes, pigmentary phenotypes, 
and risk of skin cancer in Caucasians. Int J Cancer. 2009a; 125:909–17. [PubMed: 19384953] 
Nan H, Kraft P, Qureshi AA, Guo Q, Chen C, Hankinson SE, Hu FB, Thomas G, Hoover RN, 
Chanock S. Genome-wide association study of tanning phenotype in a population of European 
ancestry. J Invest Dermatol. 2009b; 129:2250–7. [PubMed: 19340012] 
Nan H, Xu M, Kraft P, Qureshi AA, Chen C, Guo Q, Hu FB, Curhan G, Amos CI, Wang L-E, et al. 
Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell 
carcinoma and squamous cell carcinoma. Hum Mol Genet. 2011; 20:3718–24. [PubMed: 
21700618] 
Nelson MR, Bryc K, King KS, Indap A, Boyko AR, Novembre J, Briley LP, Maruyama Y, 
Waterworth DM, Vollenweider P. The Population Reference Sample, POPRES: A Resource for 
Population, Disease, and Pharmacological Genetics Research. Am J Hum Genet. 2008; 83:347–58. 
[PubMed: 18760391] 
Panza F, Solfrizzi V, D’Introno A, Colacicco AM, Capurso C, Capurso A, Kehoe PG. Shifts in 
angiotensin I converting enzyme insertion allele frequency across Europe: implications for 
Alzheimer’s disease risk. J Neurol Neurosurg Psychiatry. 2003; 74:1159–61. [PubMed: 12876265] 
Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 
diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective 
registration study. Lancet. 2009; 373:2027–33. [PubMed: 19481249] 
Chen et al. Page 17
Genet Epidemiol. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet. 2006; 2:e190. 
[PubMed: 17194218] 
Price AL, Butler J, Patterson N, Capelli C, Pascali VL, Scarnicci F, Ruiz-Linares A, Groop L, Saetta 
Aa, Korkolopoulou P, et al. Discerning the Ancestry of European Americans in Genetic 
Association Studies. PLoS Genet. 2008; 4:e236. [PubMed: 18208327] 
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick Na, Reich D. Principal components 
analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38:904–9. 
[PubMed: 16862161] 
Price AL, Zaitlen NA, Reich D, Patterson N. New approaches to population stratification in genome-
wide association studies. Nat Rev Genet. 2010; 11:459–63. [PubMed: 20548291] 
Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, Sklar P. Common 
polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009; 
460:748–52. [PubMed: 19571811] 
Qi L, Cornelis MC, Kraft P, Stanya KJ, Linda Kao WH, Pankow JS, Dupuis J, Florez JC, Fox CS, Paré 
G, et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol 
Genet. 2010; 19:2706–15. [PubMed: 20418489] 
Rietveld CA, Medland SE, Derringer J, Yang J, Esko T, Martin NW, Westra H-J, Shakhbazov K, 
Abdellaoui A, Agrawal A, et al. GWAS of 126,559 individuals identifies genetic variants 
associated with educational attainment. Science. 2013; 340:1467–71. [PubMed: 23722424] 
Rimm EB, Giovannucci EL, Willett WC, Colditz Ga, Ascherio A, Rosner B, Stampfer MJ. Prospective 
study of alcohol consumption and risk of coronary disease in men. Lancet. 1991; 338:464–8. 
[PubMed: 1678444] 
Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans PA, Lee P, Bulik-Sullivan B, Collier 
DA, Huang H, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 
2014; 511:421–7. [PubMed: 25056061] 
Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001; 22:117–39. 
[PubMed: 11603614] 
Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI, Ripke S, Santangelo S, 
Sullivan PF. Identification of risk loci with shared effects on five major psychiatric disorders: a 
genome-wide analysis. Lancet. 2013; 381:1371–9. [PubMed: 23453885] 
So H, Kwan JSH, Cherny SS, Sham PC. Risk prediction of complex diseases from family history and 
known susceptibility loci, with applications for cancer screening. Am J Hum Genet. 2011; 88:548–
65. [PubMed: 21529750] 
Stahl EA, Wegmann D, Trynka G, Gutierrez-Achury J, Do R, Voight BF, Kraft P, Chen R, Kallberg 
HJ, Kurreeman FS, et al. Bayesian inference analyses of the polygenic architecture of rheumatoid 
arthritis. Nat Genet. 2012; 44:483–9. [PubMed: 22446960] 
Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Magnusson KP, Manolescu A, Karason 
A, Palsson A, Thorleifsson G, et al. Genetic determinants of hair, eye and skin pigmentation in 
Europeans. Nat Genet. 2007; 39:1443–52. [PubMed: 17952075] 
Taylor E, Stampfer M, Curhan G. Obesity, weight gain, and the risk of kidney stones. J Am Med 
Assoc. 2005; 293:455–62.
The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human 
genomes. Nature. 2012; 491:56–65. [PubMed: 23128226] 
Turchin MC, Chiang CWK, Palmer CD, Sankararaman S, Reich D, Hirschhorn JN. Evidence of 
widespread selection on standing variation in Europe at height-associated SNPs. Nat Genet. 2012; 
44:1015–9. [PubMed: 22902787] 
Vazquez AI, de Los Campos G, Klimentidis YC, Rosa GJM, Gianola D, Yi N, Allison DB. A 
comprehensive genetic approach for improving prediction of skin cancer risk in humans. Genetics. 
2012; 192:1493–502. [PubMed: 23051645] 
Visscher PM, Brown MA, McCarthy MI, Yang J. Five Years of GWAS Discovery. Am J Hum Genet. 
2012; 90:7–24. [PubMed: 22243964] 
Wei Z, Wang K, Qu H-Q, Zhang H, Bradfield J, Kim C, Frackleton E, Hou C, Glessner JT, Chiavacci 
R, et al. From disease association to risk assessment: an optimistic view from genome-wide 
association studies on type 1 diabetes. PLoS Genet. 2009; 5:e1000678. [PubMed: 19816555] 
Chen et al. Page 18
Genet Epidemiol. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Wei Z, Wang W, Bradfield J, Li J, Cardinale C, Frackelton E, Kim C, Mentch F, Steen KV, Visscher 
PM, et al. Large sample size, wide variant spectrum, and advanced machine-learning technique 
boost risk prediction for inflammatory bowel disease. Am J Hum Genet. 2013; 92:1008–12. 
[PubMed: 23731541] 
Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, Chu AY, Estrada K, Luan J, Kutalik 
Z, et al. Defining the role of common variation in the genomic and biological architecture of adult 
human height. Nat Genet. 2014; 46:1173–86. [PubMed: 25282103] 
Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk to disease from genome-
wide association studies. Genome Res. 2007; 17:1520–8. [PubMed: 17785532] 
Wray NR, Yang J, Hayes BJ, Price AL, Goddard ME, Visscher PM. Pitfalls of predicting complex 
traits from SNPs. Nat Rev Genet. 2013; 14:507–15. [PubMed: 23774735] 
Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: A Tool for Genome-wide Complex Trait 
Analysis. Am J Hum Genet. 2010; 88:76–82. [PubMed: 21167468] 
Yang J, Zaitlen N, Goddard ME, Visscher PM, Price AL. Advantages and pitfalls in the application of 
mixed-model association methods. Nat Genet. 2014; 46:100–6. [PubMed: 24473328] 
Zhou X, Carbonetto P, Stephens M. Polygenic modeling with bayesian sparse linear mixed models. 
PLoS Genet. 2013; 9:e1003264. [PubMed: 23408905] 
Chen et al. Page 19
Genet Epidemiol. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. PCA plots for tanning ability GWAS samples, color-coded with self-reported ancestry
Black circles with color-coded interior denote average PC values for each self-reported 
ancestry. The tanning ability GWAS had the largest samples size among the 3 GWAS 
analyzed. Results for hair color and basal cell carcinoma GWAS samples, which are largely 
overlapped with the tanning ability GWAS samples, were extremely similar.
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Figure 2. R2 for polygenic prediction using PRS with different association p-value thresholds, 
GRS and PCs in 10-fold cross-validation
(A): Hair color (B): Tanning ability (C): Basal cell carcinoma
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Table 5
Comparison between prediction R2 of PRSunadj, PRSadj, and PRSadj + ancestry in simulations with different 
training sample sizes
The fluctuations in R2 of PRSunadj are not statistically significant based on the number of simulations 
performed.
R2
Training sample size (N) PRSunadj (SE) PRSadj (SE) PRSadj + ancestry (SE)
1,000 0.041 (0.0016) 0.003 (0.0002) 0.042 (0.0016)
5,000 0.041 (0.0020) 0.014 (0.0004) 0.051 (0.0019)
10,000 0.043 (0.0019) 0.027 (0.0005) 0.064 (0.0018)
50,000 0.045 (0.0020) 0.111 (0.011) 0.139 (0.0019)
100,000 0.044 (0.0020) 0.182 (0.0011) 0.201 (0.0017)
500,000 0.042 (0.0020) 0.380 (0.0015) 0.384 (0.0016)
1,000,000 0.042 (0.0018) 0.439 (0.0012) 0.440 (0.0013)
SE: standard error
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